$0.00
Molecular diagnostics for infections have entered a new era. With next-morning PCR testing now accessible across the country, providers and patients are embracing faster, more targeted care—improving outcomes, supporting antimicrobial stewardship, and reducing unnecessary treatments.
Yet reimbursement models haven’t kept up. Payors have an opportunity to better align with the value next-morning diagnostics bring to the healthcare system.
In this webinar, HealthTrackRx and The Leapfrog Group break down why fast, accurate testing is essential for better patient care. Our panel of experts explores misdiagnosis, rising antibiotic resistance, and how next-morning PCR results help clinicians make quicker, better decisions.
e targeted care—improving outcomes, supporting antimicrobial stewardship, and reducing unnecessary treatments.
Yet reimbursement models haven’t kept up. Payors have an opportunity to better align with the value next-morning diagnostics bring to the healthcare system.
This panel brings together nationally recognized experts in population health, infectious disease, and healthcare economics to explore the clinical impact of next-morning testing and what’s needed to support responsible innovation in diagnostics.
• David B. Nash, MD, MBA – Founding Dean Emeritus of the Jefferson College of Population Health, board-certified internist, and renowned expert in health policy, population health, and quality improvement.
• Barbara D. Alexander, MD – Professor of Medicine and Pathology at Duke University, board-certified in Infectious Diseases and Medical Microbiology, and a leading voice in clinical infectious disease care and stewardship.
• Steven Goldberg, MD, MBA – Chief Medical Officer at HealthTrackRx, named one of Modern Healthcare’s “100 Most Influential in Healthcare,” with deep expertise in clinical operations, population health, and healthcare economics.
• Leah Binder, MA, MGA – President & CEO of The Leapfrog Group, one of the most influential people in health care (Modern Healthcare, Beckers), who brings the voices of purchasers together to push for transparency in the health care market. National voice on health care value and contributor to Forbes.com and Huffington Post.
What You’ll Learn:
• Real-world impact of next-morning PCR testing on clinical workflows and patient outcomes
• How diagnostic speed supports antibiotic stewardship and lowers total cost of care
• Gaps in current reimbursement policy and implications for quality and access
• What forward-thinking employers, payors, and health systems can do to lead
| Source | HealthTrackRx |
|---|---|
| Length | 1 hour |
| Future Review Date | December 2026 |
| Publication Date | 12/18/2025 |
| Contributor | David B. Nash, MD, MBA, Barbara D. Alexander, MD, Steven Goldberg, MD, MBA, Leah Binder, MA, MGA |
| Format | Webinar |